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Chronic relapsing neutrophilic meningitis as the sole manifestation of
nocardiosis in a patient with mixed connective tissue disease
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We describe a rare case of a patient with mixed connective tissue disease maintained on chronic oral
corticosteroids, who was hospitalized on five occasions over five consecutive months due to persistent
relapsing neutrophilic meningitis caused by Nocardia asteroides. Immunosuppression due to the chronic use
of corticosteroids was identified as the underlying mechanism of susceptibility. Our report highlights the
challenges associated with systemic Nocardiosis, particularly in the immunocompromised host.
© 2022 Published by Elsevier Ltd.
CC_BY_NC_ND_4.0
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Introduction
Persistent neutrophilic meningitis (PNM), characterized by cerebrospinal fluid (CSF) neutrophilia, hypoglycorrhachia and meningismus lasting more than seven days despite antibiotic therapy, is
an infrequent variant of chronic meningitis caused by heterogeneous
infectious and non-infectious etiologies [1]. Due to the highly variable clinical manifestations associated with Nocardial infections,
diagnostic and therapeutic challenges are commonly encountered
that, if not recognized and addressed early and appropriately, may
result in high levels of morbidity and mortality [2,3]. Nocardia meningitis in the absence of a cerebral abscess, trauma or extracranial
foci is extremely rare with only seven well-documented cases reported in the English literature [4–7]. We describe a patient with
polymyositis-predominant mixed connective tissue disease (MCTD),
well-controlled on hydroxychloroquine and chronic glucocorticoid
therapy, who was hospitalized on five occasions over five consecutive months due to relapsing neutrophilic meningitis. A prompt,
albeit transitory, salutary response to poly-antimicrobial regimens
occurred during each admission, eventually followed by the identification of Nocardia asteroides. To our knowledge, this is the first
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reported case of primary relapsing neutrophilic Nocardia meningitis
in the absence of a cerebral abscess in a patient with a connective
tissue disease.
Case report
The patient is a 48-year-old African-American female diagnosed
on May 7th with MCTD featuring biopsy-proven polymyositis with a
peak CK of 5400 in the company of very low-grade limited cutaneous
scleroderma, mild symmetrical polyarthralgias and a high-titer RNP
antibody. Prednisone 30 mg bid and hydroxychloroquine 200 mg bid
were started concurrently with the diagnosis. Seven weeks after
tapering prednisone to 12.5 mg daily, and the continued use of hydroxychloroquine, clinical and laboratory myopathic abnormalities
normalized. On August 2, she developed the abrupt onset of a 101.2
degree fever with chills, prominent fatigue and profound anorexia.
Over the ensuing 48 h, fevers climbed to 103 degrees which led to
hospitalization on August 8th. On admission, vitals were BP 130/70,
temperature of 103.1, respirations 14 and heart rate 108. She appeared non-toxic with a normal mental status and in good humor.
Other than mild cutaneous tumefaction involving the dorsal aspect
of both hands, the remainder of the examination was normal. A
lumbar puncture revealed meningitis that improved with antimicrobial therapy. Headaches and fevers preceded all subsequent
hospitalizations, yet the patient’s physical examinations never revealed meningeal signs or the presence of focal neurological, myopathic or new extra-neural abnormalities. During each hospital stay,
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Table 1
Laboratory, imaging, and therapeutic data from 5 hospital admissions over a consecutive 5-month period.

mild anemia, leukocytosis and elevation of ESR were consistently
present
without
notable
biochemical
abnormalities.
Immunodeficiency studies and a leptomeningeal biopsy were unremarkable. A summary of pertinent clinical and laboratory data
during the five hospitalizations is presented in Table 1. After longterm susceptibility-based antimicrobial therapy was completed, the
patient returned to her healthy premorbid state and remained disease-free for 6 years at which point she moved out of state and was
lost to follow-up.

(CNS) infection. In a noteworthy report of 28 patients with Nocardia
meningitis, over 30% did not exhibit fever, headaches or meningismus, despite the presence of isolated or multiple cerebral
abscesses in 43% of patients [3]. The clinical and CSF features of
Nocardia meningitis lack any distinctive features that would permit
differentiation from other causes of bacterial meningitis [3]. Moreover, there are no historical, physical examination, laboratory or
imaging findings pathognomonic of Nocardiosis. Dissemination of
infection is typically via the hematogenous route, whereas presenting manifestations are most commonly in the form of pulmonary findings, followed by CNS and cutaneous features [8]. A
mode of acquisition was not established in our patient. Approximately two-thirds of patients suffering from Nocardia infections are
immunosuppressed, most commonly by virtue of cell-mediated
dysregulation in the context of chronic corticosteroid usage [8,10].
Solid organ and bone marrow transplantation, non-corticosteroid
immunosuppressive pharmacotherapies, malignancies, and an array
of chronic debilitating illnesses represent the remainder of major
predisposing factors [8]. The clinical manifestations of MCTD in our
patient were overrepresented by polymyositis mediated activity,
with low-grade acral cutaneous scleroderma and polyarthralgias. In
the absence of corticosteroid or other immunosuppressive therapies,
patients with polymyositis and scleroderma are not considered to
have an inherently higher risk of developing an opportunistic
infection.
Delays in the diagnosis of Nocardiosis are well recognized and
most commonly due to a potentially wide spectrum of clinical
manifestations, a reduced index of suspicion, inadequate or inappropriate laboratory methodologies, the fastidious, slow-growing
nature of the organism, and the abbreviated duration and/or bacteriostatic effects of empiric antibiotic therapy [11]. It has been reported that the time required to establish a diagnosis ranges from 6

Discussion
Nocardiae are ubiquitous, saprophytic, weakly gram-positive
bacilli characterized by their ability to cause disseminated disease
involving any organ and to worsen or relapse even in the presence of
appropriate bactericidal therapy [2,3]. In immunocompromised patients with persistent infectious neutrophilic meningitis, Nocardia,
Aspergillus, Mycobacteria and a number of fungal species represent
the most commonly encountered organisms [2]. Due to advancements over the past three decades in molecular genetics and the
detection of species-specific susceptibilities to antibiotic therapy, the
taxonomy of Nocardia has been greatly refined, with the identification of greater than 50 species that are disease-inducing in humans
[8]. The frequency of species varies depending on geographic location with Nocardia nova most commonly isolated in the U.S. (28%),
followed in frequency by N. brasiliensis (14%), N. farcinica (14%), N.
cyriacigeorgica (13%), N. brevicatena (7%), and N. abscessus (6%) [9].
Nocardia exhibits a heightened proclivity to invade neural tissues,
particularly in the setting of disseminated disease, and does so most
commonly in the form of an intracerebral abscess [10–12]. However,
immunocompetent and immunosuppressed patients may exhibit
little to no symptoms or signs suggestive of central nervous system
2

M.A. Albornoz, E.K. Threlfall, M.P. Baldassari et al.

IDCases 28 (2022) e01473

weeks to 12 months [8,13]. The gold standard for confirming Nocardial infection is culture-proven identification of the pathogen
from an afflicted site, which, in most cases of Nocardia infection,
requires an invasive procedure to retrieve the compromised tissue
[2,3,11]. The armamentarium of available microbiologic diagnostic
methodologies include dual gram and modified acid-fast staining,
culture of affected tissues, histopathological analysis and molecular
biologic techniques [3]. From an imaging perspective, with the
possible exception of cutaneous infection occurring in an immunologically intact host, it is recommended that all patients with
Nocardiosis, particularly those infected with N. asteroides, with or
without neurological abnormalities, obtain an MRI or less preferably
a CT of the brain [14].
In patients with PNM, bacterial infection is the most commonly
identified etiology, with rheumatologic, neoplastic and drug-induced conditions less frequently represented [2]. In most cases, relapsing infectious meningitis is due to improperly selected
antimicrobials, host immune deficiencies, and pathogen-related
barriers, be they drug resistance or mechanical impairment to drug
penetration as occurs with an abscess or anatomic anomalies [10,12].
In the diagnosis and management of chronic meningitis, great emphasis should be placed on conducting a meticulous analysis of
epidemiological and clinical findings as early pathogen identification, particularly in the context of opportunistic organisms, frequently results in favorable outcomes [10,13]. In a review of the
connective tissue disease population, primary non-relapsing Nocardia meningitis is limited to two patients with systemic lupus
erythematosus, one with chronic meningitis not responsive to antibiotics in which the diagnosis was made post-mortem and the
other associated with the use of belimumab and mycophenolate [6,7].
Nocardia species determination, clinical presentation, and antibiotic susceptibility profiles are major factors that determine the
selection of appropriate antibiotic regimens [10,11]. Low Nocardia
resistance rates of 2% to trimethoprim-sulfamethoxazole (TMP-SMX)
or sulfamethoxazole alone, coupled with the ability of TMP-SMX to
penetrate most body tissues and achieve high CNS concentrations,
explains why this agent is considered the cornerstone of induction
and maintenance therapy [12,13]. In view of the inherent relapse
potential seen in Nocardiosis, in-depth patient education, drug
toxicity assessment and close clinical monitoring are strongly recommended [3,12,13]. A defined sequence of MRI scanning of the
brain both during and after completion of therapy in patients with
CNS disease has been formulated [15].
In this report, our patient, who was maintained on chronic corticosteroid therapy, demonstrated no clinical, laboratory or imaging
findings suggesting a primary focus of Nocardial infection, nor evidence of any anatomic defect that could facilitate contiguous spread
to the brain. Moreover, a leptomeningeal biopsy was performed with
the dual aim of facilitating pathogen identification and excluding
neoplastic, vasculitic or other inflammatory diseases. Initial and
subsequent presentations were typical of bacterial meningitis, and
on each occasion, cultures failed to grow any organism, potentially
due to transient sterilization and difficulty cultivating the organism
from the CSF. Meningitis recurred when empiric antimicrobial
therapy was discontinued and, on one occasion, while on ineffective
antibiotics. Once a diagnosis was established and drug sensitivities
were available, the introduction of an appropriate antibiotic regimen
resulted in a complete, multi-year resolution of clinical and CSF
abnormalities.
As our case reveals, Nocardiosis, although an infrequent cause of
meningitis, should be considered in the differential diagnosis of
PNM, particularly in an immunocompromised host exposed to long-

term corticosteroid therapy. Multiple clinical and laboratory obstacles contribute to the delay of appropriate therapy in this subset
of patients thereby greatly heightening the risk of life-threatening
outcomes.
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